1. Home
  2. ENZ vs FAAS Comparison

ENZ vs FAAS Comparison

Compare ENZ & FAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • FAAS
  • Stock Information
  • Founded
  • ENZ 1976
  • FAAS 2021
  • Country
  • ENZ United States
  • FAAS Indonesia
  • Employees
  • ENZ N/A
  • FAAS N/A
  • Industry
  • ENZ Medical Specialities
  • FAAS
  • Sector
  • ENZ Health Care
  • FAAS
  • Exchange
  • ENZ Nasdaq
  • FAAS NYSE
  • Market Cap
  • ENZ 34.2M
  • FAAS 34.6M
  • IPO Year
  • ENZ N/A
  • FAAS N/A
  • Fundamental
  • Price
  • ENZ $0.48
  • FAAS $0.50
  • Analyst Decision
  • ENZ
  • FAAS
  • Analyst Count
  • ENZ 0
  • FAAS 0
  • Target Price
  • ENZ N/A
  • FAAS N/A
  • AVG Volume (30 Days)
  • ENZ 139.1K
  • FAAS 470.5K
  • Earning Date
  • ENZ 03-12-2025
  • FAAS 09-17-2024
  • Dividend Yield
  • ENZ N/A
  • FAAS N/A
  • EPS Growth
  • ENZ N/A
  • FAAS N/A
  • EPS
  • ENZ N/A
  • FAAS N/A
  • Revenue
  • ENZ $30,314,000.00
  • FAAS $57,730,593.00
  • Revenue This Year
  • ENZ N/A
  • FAAS N/A
  • Revenue Next Year
  • ENZ N/A
  • FAAS N/A
  • P/E Ratio
  • ENZ N/A
  • FAAS N/A
  • Revenue Growth
  • ENZ N/A
  • FAAS 38.16
  • 52 Week Low
  • ENZ $0.49
  • FAAS $0.38
  • 52 Week High
  • ENZ $1.40
  • FAAS $13.64
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 18.73
  • FAAS 43.86
  • Support Level
  • ENZ $0.56
  • FAAS $0.43
  • Resistance Level
  • ENZ $0.69
  • FAAS $0.85
  • Average True Range (ATR)
  • ENZ 0.04
  • FAAS 0.12
  • MACD
  • ENZ -0.00
  • FAAS 0.01
  • Stochastic Oscillator
  • ENZ 24.67
  • FAAS 15.63

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About FAAS DIGIASIA CORP

DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.

Share on Social Networks: